Details

NameSymbolSector
LINCOLN PHARMACEUTICALS LIMITEDLINCOLNPharmaceuticals
Open
545
High
549
Low
541
Close
542.65
Volume
26912
Exchange
nse
Time
14/08

Outlook

Score:  

1.75

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Lincoln Pharmaceuticals is  
Short Line
Estimated Stoploss of Lincoln Pharmaceuticals is ₹  
549
Lincoln Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
Short Line
 candle pattern indicates the trend direction of Lincoln Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Lincoln Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Lincoln Pharmaceuticals is  
Downℹ
 by  

2.15

%. 
Target
Buy @ 

527.43

Sell @ 

588.39

Volume

The trade volumes of Lincoln Pharmaceuticals have become  
Deficientℹ
The volume trend for Lincoln Pharmaceuticals is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Lincoln Pharmaceuticals is  

Down

 by  

81.25

% 

Valuation

The current market price of Lincoln Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
The balance sheet of Lincoln Pharmaceuticals is:  

Balanced

Cashflow
Lincoln Pharmaceuticals has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 7cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2025)

52.54% i.e. ₹ 93cr earned in operatingℹ
44.07% i.e. ₹ 78cr spent in investingℹ
3.39% i.e. ₹ 6cr spent in financingℹ
0% in otherℹ
Lincoln Pharmaceuticals has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

100

%. 

(*Mar 2024)

50.4% i.e. ₹ 63cr earned in operatingℹ
45.6% i.e. ₹ 57cr spent in investingℹ
4% i.e. ₹ 5cr spent in financingℹ
0% in otherℹ
Income
The income of Lincoln Pharmaceuticals is  

₹ 169cr

 and  

Profit

 is :  

₹ 27cr

(*Jun 2025)

Lincoln Pharmaceuticals Profit is up by:  

145.45

% and Income is Up by:  

4.97

% 

(*Jun 2025)

The income of Lincoln Pharmaceuticals is  

₹ 161cr

 and  

Profit

 is :  

₹ 11cr

(*Mar 2025)

Lincoln Pharmaceuticals Profit is down by:  

45

% and Income is Up by:  

3.87

% 

(*Mar 2025)

The income of Lincoln Pharmaceuticals is  

₹ 155cr

 and  

Profit

 is :  

₹ 20cr

(*Dec 2024)

Lincoln Pharmaceuticals Profit is down by:  

23.08

% and Income is Down by:  

9.36

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.